| 1 |
26354948 | Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study. | 2015 Nov |
3 |
| 2 |
24947467 | Blood-brain barrier pharmacoproteomics-based reconstruction of the in vivo brain distribution of P-glycoprotein substrates in cynomolgus monkeys. | 2014 Sep |
2 |
| 3 |
23976943 | Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp. | 2013 |
1 |
| 4 |
20196146 | Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells. | 2011 Aug |
2 |
| 5 |
21725799 | Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer. | 2011 Sep |
4 |
| 6 |
22028772 | Fitting the elementary rate constants of the P-gp transporter network in the hMDR1-MDCK confluent cell monolayer using a particle swarm algorithm. | 2011 |
2 |
| 7 |
19816852 | Development and validation of RP-HPLC-fluorescence method for quantitative determination of quinidine, a probe substrate for P-glycoprotein inhibition assay using Caco-2 cell monolayer. | 2010 Jun |
1 |
| 8 |
19248230 | Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. | 2009 Jan-Feb |
1 |
| 9 |
15501934 | The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells. | 2005 Jan |
4 |
| 10 |
15266218 | In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. | 2004 Jul-Aug |
1 |